ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

Cancer Commission Surveying for Pill, Hepatoma Association

October 1, 1976

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

President Obama Signs FDA User Fee Act Into Law

July 13, 2012